Search

Your search keyword '"Humphries, S. E."' showing total 63 results

Search Constraints

Start Over You searched for: Author "Humphries, S. E." Remove constraint Author: "Humphries, S. E." Topic polymorphism, genetic Remove constraint Topic: polymorphism, genetic
63 results on '"Humphries, S. E."'

Search Results

1. Polymorphisms in the angiotensin converting enzyme gene and growth in the first year of life.

2. The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms.

3. Polymorphism of the heme oxygenase-1 gene and cerebral aneurysms.

4. Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study.

5. The -344T>C promoter variant of the gene for aldosterone synthase (CYP11B2) is not associated with cardiovascular risk in a prospective study of UK healthy men.

6. The plasminogen activator inhibitor-1 -675 4G/5G genotype influences the risk of myocardial infarction associated with elevated plasma proinsulin and insulin concentrations in men from Europe: the HIFMECH study.

7. Human CRP gene polymorphism influences CRP levels: implications for the prediction and pathogenesis of coronary heart disease.

8. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women.

9. The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis.

11. Genetic determinants of the response to bezafibrate treatment in the lower extremity arterial disease event reduction (LEADER) trial.

12. Endurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to training.

13. The -629C>A polymorphism in the CETP gene does not explain the association of TaqIB polymorphism with risk and age of myocardial infarction in Icelandic men.

14. Genetic polymorphisms, lipoproteins and coronary artery disease risk.

15. The effect of the C677T and A1298C polymorphisms in the methylenetetrahydrofolate reductase gene on homocysteine levels in elderly men and women from the British regional heart study.

16. Polymorphisms in the thrombopoietin gene are associated with risk of myocardial infarction at a young age.

17. Left ventricular hypertrophy with exercise and ACE gene insertion/deletion polymorphism: a randomized controlled trial with losartan.

18. Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men.

19. Polymorphisms in the lipoprotein lipase and hepatic lipase genes and plasma lipid values in the Czech population.

20. The ACE I/D polymorphism and human physical performance.

22. Regular exercise, plasminogen activator inhibitor-1 (PAI-1) activity and the 4G/5G promoter polymorphism in the PAI-1 gene.

24. Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins.

25. The use of a highly informative CA repeat polymorphism within the abetalipoproteinaemia locus (4q22-24).

26. Apal polymorphism in insulin-like growth factor II (IGF2) gene and weight in middle-aged males.

27. Interaction of the cholesteryl ester transfer protein I405V polymorphism with alcohol consumption in smoking and non-smoking healthy men, and the effect on plasma HDL cholesterol and apoAI concentration.

28. Association of genetic variation at the beta-fibrinogen gene locus and plasma fibrinogen levels; interaction between allele frequency of the G/A-455 polymorphism, age and smoking.

29. Lack of association of angiotensin-converting enzyme (ACE). Gene insertion/deletion polymorphism with CAD in two Asian populations.

30. Use of the single strand conformation polymorphism method for rapid screening for mutations in the low density lipoprotein receptor gene in patients with familial hypercholesterolemia: effect on plasma lipid levels of different classes of mutations.

31. The 4G/5G genetic polymorphism in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene is associated with differences in plasma PAI-1 activity but not with risk of myocardial infarction in the ECTIM study. Etude CasTemoins de I'nfarctus du Mycocarde.

32. The association of combined alpha and beta fibrinogen genotype on plasma fibrinogen levels in smokers and non-smokers.

33. Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example.

34. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: the European Atherosclerosis Research Study.

35. DNA polymorphisms of the apolipoprotein B gene are associated with obesity and serum lipids in healthy Indians in Singapore.

36. Description of a dinucleotide repeat polymorphism in the human elastin gene and its use to confirm assignment of the gene to chromosome 7.

37. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden.

38. DNA polymorphism studies. Approaches to elucidating multifactorial ischaemic heart disease: the apo B gene as an example.

39. Interaction between a polymorphism of the apo A-I promoter region and smoking determines plasma levels of HDL and apo A-I.

40. Polymorphisms in the apolipoprotein (apo) AI-CIII-AIV gene cluster: detection of genetic variation determining plasma apo AI, apo CIII and apo AIV concentrations.

41. Genetic relationship between the 3'-VNTR and diallelic apolipoprotein B gene polymorphisms: haplotype analysis in individuals of European and south Asian origin.

42. Apolipoprotein B-gene DNA polymorphisms (XbaI and EcoRI), serum lipids, and apolipoproteins in healthy Chinese.

43. Apolipoprotein B gene polymorphisms are associated with lipid levels in men of South Asian descent.

44. Variation in the promoter region of the beta fibrinogen gene is associated with plasma fibrinogen levels in smokers and non-smokers.

45. Within-individual variation in serum cholesterol levels: association with DNA polymorphisms at the apolipoprotein B and AI-CIII-AIV loci in patients with peripheral arterial disease.

46. Apolipoprotein E polymorphism and plasma lipid, lipoprotein, and apolipoprotein levels in Italian children.

47. Detection of apolipoprotein E polymorphisms using PCR/ASO probes and Southern transfer: application for routine use.

48. Association between epitopes detected by monoclonal antibody BIP-45 and the XbaI polymorphism of apolipoprotein B.

49. Restriction fragment length polymorphisms in the apo B gene in relation to coronary artery disease.

Catalog

Books, media, physical & digital resources